254 related articles for article (PubMed ID: 28400279)
1. SNHG1 lncRNA negatively regulates miR-199a-3p to enhance CDK7 expression and promote cell proliferation in prostate cancer.
Li J; Zhang Z; Xiong L; Guo C; Jiang T; Zeng L; Li G; Wang J
Biochem Biophys Res Commun; 2017 May; 487(1):146-152. PubMed ID: 28400279
[TBL] [Abstract][Full Text] [Related]
2. LncRNA SNHG1 influences cell proliferation, migration, invasion, and apoptosis of non-small cell lung cancer cells via the miR-361-3p/FRAT1 axis.
Li X; Zheng H
Thorac Cancer; 2020 Feb; 11(2):295-304. PubMed ID: 31788970
[TBL] [Abstract][Full Text] [Related]
3. Upregulated lncRNA SNHG1 contributes to progression of non-small cell lung cancer through inhibition of miR-101-3p and activation of Wnt/β-catenin signaling pathway.
Cui Y; Zhang F; Zhu C; Geng L; Tian T; Liu H
Oncotarget; 2017 Mar; 8(11):17785-17794. PubMed ID: 28147312
[TBL] [Abstract][Full Text] [Related]
4. LncRNA SNHG1 upregulates FANCD2 and G6PD to suppress ferroptosis by sponging miR-199a-5p/3p in hepatocellular carcinoma.
Zhou L; Zhang Q; Cheng J; Shen X; Li J; Chen M; Zhou C; Zhou J
Drug Discov Ther; 2023 Sep; 17(4):248-256. PubMed ID: 37599085
[TBL] [Abstract][Full Text] [Related]
5. LncRNA SNHG1 contributes to the regulation of acute myeloid leukemia cell growth by modulating miR-489-3p/SOX12/Wnt/β-catenin signaling.
Li C; Gao Q; Wang M; Xin H
J Cell Physiol; 2021 Jan; 236(1):653-663. PubMed ID: 32592199
[TBL] [Abstract][Full Text] [Related]
6. The HIF-1/SNHG1/miR-199a-3p/TFAM axis explains tumor angiogenesis and metastasis under hypoxic conditions in breast cancer.
Zuo Y; Qu C; Tian Y; Wen Y; Xia S; Ma M
Biofactors; 2021 May; 47(3):444-460. PubMed ID: 34003544
[TBL] [Abstract][Full Text] [Related]
7. Long Noncoding RNA
Xie M; Zhang Z; Cui Y
Cancer Biother Radiopharm; 2020 Mar; 35(2):109-119. PubMed ID: 32077748
[No Abstract] [Full Text] [Related]
8. LncRNA SNHG1 contributes to tumorigenesis and mechanism by targeting miR-338-3p to regulate PLK4 in human neuroblastoma.
Zhang N; Liu FL; Ma TS; Zhang ZZJ
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8971-8983. PubMed ID: 31696485
[TBL] [Abstract][Full Text] [Related]
9. Positive feedback loop SP1/SNHG1/miR-199a-5p promotes the malignant properties of thyroid cancer.
Ding W; Zhao S; Shi Y; Chen S
Biochem Biophys Res Commun; 2020 Feb; 522(3):724-730. PubMed ID: 31791587
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA SNHG1 promotes human prostate cancer progression by sponging miR-383-5p.
Huang G; Guo X; Yang H
Anticancer Drugs; 2021 Mar; 32(3):286-295. PubMed ID: 33470616
[TBL] [Abstract][Full Text] [Related]
11. LncRNA Snhg1, a non-degradable sponge for miR-338, promotes expression of proto-oncogene CST3 in primary esophageal cancer cells.
Yan Y; Fan Q; Wang L; Zhou Y; Li J; Zhou K
Oncotarget; 2017 May; 8(22):35750-35760. PubMed ID: 28423738
[TBL] [Abstract][Full Text] [Related]
12. Regulatory mechanism of lncRNA NORAD on proliferation and invasion of ovarian cancer cells through miR-199a-3p.
Xu C; Zhu LX; Sun DM; Yao H; Han DX
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1672-1681. PubMed ID: 32141533
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA SNHG1 functions as a competitive endogenous RNA to regulate PDCD4 expression by sponging miR-195-5p in hepatocellular carcinoma.
Huang D; Wei Y; Zhu J; Wang F
Gene; 2019 Sep; 714():143994. PubMed ID: 31330233
[TBL] [Abstract][Full Text] [Related]
14. The SNHG1-Centered ceRNA Network Regulates Cell Cycle and Is a Potential Prognostic Biomarker for Hepatocellular Carcinoma.
Zhou L; Zhang Q; Deng H; Ou S; Liang T; Zhou J
Tohoku J Exp Med; 2022 Nov; 258(4):265-276. PubMed ID: 36244757
[TBL] [Abstract][Full Text] [Related]
15. The long noncoding RNA SNHG1 regulates colorectal cancer cell growth through interactions with EZH2 and miR-154-5p.
Xu M; Chen X; Lin K; Zeng K; Liu X; Pan B; Xu X; Xu T; Hu X; Sun L; He B; Pan Y; Sun H; Wang S
Mol Cancer; 2018 Sep; 17(1):141. PubMed ID: 30266084
[TBL] [Abstract][Full Text] [Related]
16. miR-199a/214 cluster enhances prostate cancer sensitiveness to nimotuzumab via targeting TBL1XR1.
Hu S; Zhou Q; Lu Q; Guo X; Wang Y; Duan YX
Kaohsiung J Med Sci; 2023 Dec; 39(12):1178-1189. PubMed ID: 37772770
[TBL] [Abstract][Full Text] [Related]
17. miR-199a-3p targets stemness-related and mitogenic signaling pathways to suppress the expansion and tumorigenic capabilities of prostate cancer stem cells.
Liu R; Liu C; Zhang D; Liu B; Chen X; Rycaj K; Jeter C; Calhoun-Davis T; Li Y; Yang T; Wang J; Tang DG
Oncotarget; 2016 Aug; 7(35):56628-56642. PubMed ID: 27447749
[TBL] [Abstract][Full Text] [Related]
18. miR-199a-3p inhibits aurora kinase A and attenuates prostate cancer growth: new avenue for prostate cancer treatment.
Qu Y; Huang X; Li Z; Liu J; Wu J; Chen D; Zhao F; Mu D
Am J Pathol; 2014 May; 184(5):1541-9. PubMed ID: 24631181
[TBL] [Abstract][Full Text] [Related]
19. LncRNA SNHG1 promotes cell progression and metastasis via sponging miR-377-3p in hepatocellular carcinoma.
Qu A; Yang Q
Neoplasma; 2020 May; 67(3):557-566. PubMed ID: 32122143
[TBL] [Abstract][Full Text] [Related]
20. LncRNA SNHG1 contributes to the cisplatin resistance and progression of NSCLC via miR-330-5p/DCLK1 axis.
Ge P; Cao L; Zheng M; Yao Y; Wang W; Chen X
Exp Mol Pathol; 2021 Jun; 120():104633. PubMed ID: 33753110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]